WO2026009168 - TRANSCRIPTION ARRAY
National phase entry is expected:
Publication Number
WO/2026/009168
Publication Date
08.01.2026
International Application No.
PCT/IB2025/056718
International Filing Date
02.07.2025
Title **
[English]
TRANSCRIPTION ARRAY
[French]
RÉSEAU DE TRANSCRIPTION
Applicants **
SUN PHARMACEUTICAL INDUSTRIES AUSTRALIA PTY LIMITED
Inventors
GRAHAM, Ian
WINZER, Thilo
LI, Yi
Priority Data
2409772.7
05.07.2024
GB
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
IP Australia
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2589 | |
| EPO | Filing, Examination, Granting | 16792 | |
| Japan | Filing, Examination, Granting | 2418 | |
| South Korea | Filing, Examination, Granting | 2637 | |
| USA | Filing, Examination, Granting | 16140 |
Total:
40,576
Contact Us
Abstract[English]
The disclosure relates to transcription cassettes, expression vectors and microbial cells adapted for the expression of genes regulated by the RBA transcription factor.[French]
La divulgation concerne des cassettes de transcription, des vecteurs d'expression et des cellules microbiennes adaptées à l'expression de gènes régulés par le facteur de transcription RBA.